PTK2 and ovarian carcinoma: Amongst them, VS-6063 (formerly PF-04554878), has been reported to increase the apoptosis induced by paclitaxel, in ovarian cancer cells resistant to taxane, through the inhibition of the FAK-mediated chemoresistance signaling pathway43.